Corcept Therapeutics Inc. CORT
$114.47
+3.58%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (4 Buy · 0 Hold · 1 Sell)
- Average Price Target
- $122.60
- Implied Upside
- +7.1%
- Price Target Range
- $50.00 – $165.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-30 | Piper SandlerDavid Amsellem |
Reiterates | Overweight | $88 → $165 |
| 2026-07-30 | Canaccord GenuityEdward Nash |
Maintains | Buy | $150 → $161 |
| 2026-07-30 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $95 → $165 |
| 2026-07-29 | Canaccord GenuityEdward Nash |
Maintains | Buy | $135 → $150 |
| 2026-07-27 | Wolfe ResearchKalpit Patel |
Downgrades | Peer perform → Underperform | $50 |
| 2026-05-28 | Canaccord GenuityEdward Nash |
Maintains | Buy | $110 → $135 |
| 2026-05-28 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $75 → $95 |
| 2026-05-13 | UBSAshwani Verma |
Upgrades | Neutral → Buy | $44 → $72 |
| 2026-05-04 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $60 → $75 |
| 2026-05-01 | Piper SandlerDavid Amsellem |
Maintains | Overweight | $73 → $88 |
| 2026-03-26 | Canaccord GenuityEdward Nash |
Maintains | Buy | $100 → $110 |
| 2026-03-26 | Wolfe ResearchKalpit Patel |
Upgrades | Underperform → Peer perform | — |
| 2026-03-25 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $67 → $60 |
| 2026-02-25 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $67 → $60 |
| 2026-02-20 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $105 → $67 |
| 2026-01-23 | Canaccord GenuityEdward Nash |
Maintains | Buy | $99 → $100 |
| 2026-01-23 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $90 → $105 |
| 2026-01-02 | Canaccord GenuityEdward Nash |
Maintains | Buy | $140 → $99 |
| 2026-01-02 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $145 → $90 |
| 2025-12-16 | UBSAshwani Verma |
Initiates coverage on | Neutral | $95 |
| 2025-11-25 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $145 |
| 2025-11-18 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Peer perform | — |
| 2025-10-20 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $145 |
| 2025-10-10 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $145 |
| 2025-09-25 | Canaccord GenuityEdward Nash |
Maintains | Buy | $140 |
| 2025-09-10 | Canaccord GenuityEdward Nash |
Maintains | Buy | $137 → $140 |
| 2025-08-01 | Canaccord GenuityEdward Nash |
Maintains | Buy | $142 → $137 |
| 2025-08-01 | Piper SandlerDavid Amsellem |
Maintains | Overweight | $131 → $121 |
| 2025-05-06 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $150 → $145 |
| 2025-04-03 | Piper SandlerDavid Amsellem |
Maintains | Overweight | $128 → $131 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $114.47
- Market Cap
- $12.13 billion
- 52-Week Range
- $28.66 – $122.21
- Average Volume
- 1.24 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.